Filed: 5/15/2026ACC: 0001104659-26-062462
📋 What this filing means
FORESITE CAPITAL MANAGEMENT IV, LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $237.08M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$237.08M
Total AUM (reported)
13.23M
Total Shares
Allocation by class
COM$237.08M100.0%
Portfolio Concentration
Top 3$188.73M79.6%
4–10$48.35M20.4%
Top 3 weight
79.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 13.23M
Sole
Full voting authority
13.23M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings8
Rows:
Pharvaris N.V.
SOLEShares4.78M
TypeSH
Market value$134.99M
56.94%
Sole
4.78M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares503.30K
TypeSH
Market value$33.17M
13.99%
Sole
503.30K
Shared
0.00
None
0.00
Eikon Therapeutics, Inc.
SOLEShares1.94M
TypeSH
Market value$20.56M
8.67%
Sole
1.94M
Shared
0.00
None
0.00
Lyell Immunopharma, Inc.
SOLEShares800.40K
TypeSH
Market value$16.06M
6.77%
Sole
800.40K
Shared
0.00
None
0.00
Relay Therapeutics, Inc.
SOLEShares1M
TypeSH
Market value$9.95M
4.20%
Sole
1M
Shared
0.00
None
0.00
Xenon Pharmaceuticals Inc.
SOLEShares160K
TypeSH
Market value$9.30M
3.92%
Sole
160K
Shared
0.00
None
0.00
Alector, Inc.
SOLEShares3.89M
TypeSH
Market value$8.36M
3.53%
Sole
3.89M
Shared
0.00
None
0.00
Maze Therapeutics, Inc.
SOLEShares156.90K
TypeSH
Market value$4.68M
1.98%
Sole
156.90K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Pharvaris N.V.SOLE | COM | 4.78M | SH | $134.99M 56.94% | 4.78M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM | 503.30K | SH | $33.17M 13.99% | 503.30K | 0.00 | 0.00 |
Eikon Therapeutics, Inc.SOLE | COM | 1.94M | SH | $20.56M 8.67% | 1.94M | 0.00 | 0.00 |
Lyell Immunopharma, Inc.SOLE | COM | 800.40K | SH | $16.06M 6.77% | 800.40K | 0.00 | 0.00 |
Relay Therapeutics, Inc.SOLE | COM | 1M | SH | $9.95M 4.20% | 1M | 0.00 | 0.00 |
Xenon Pharmaceuticals Inc.SOLE | COM | 160K | SH | $9.30M 3.92% | 160K | 0.00 | 0.00 |
Alector, Inc.SOLE | COM | 3.89M | SH | $8.36M 3.53% | 3.89M | 0.00 | 0.00 |
Maze Therapeutics, Inc.SOLE | COM | 156.90K | SH | $4.68M 1.98% | 156.90K | 0.00 | 0.00 |